Retrospective audit on time to surgery delays following the completion of neoadjuvant chemotherapy in breast cancer patients
The ideal time to surgery interval in breast cancer patients following neoadjuvant chemotherapy according to published literature is as low as 21 days, 40 days and up to 8 weeks. The authors' hospital multidisciplinary team (MDT) accepted 28 days as a reasonable time interval to allow recovery...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Spandidos Publications
2022
|
| Subjects: | |
| Online Access: | View Fulltext in Publisher |